Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Boosting confidence in artificial intelligence.

Rowe1

  • 1Zeneca Pharmaceuticals, Alderley Park, Macclesfield, UK SK10 2NA.

Pharmaceutical Science & Technology Today
|May 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomechanical correlates for recovering walking speed following a stroke. The potential of tibia to vertical angle as a therapy target.

Gait & posture·2019
Same author

A retrospective analysis of palliative colonic stent placement in an elderly population.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
Same author

Poetry and verse: an ideal medium for scientific communication?

Drug discovery today·2000
Same author

DeForMing the AToM. 'Design For Manufacture and Ability To Make should be the modus operandi of all product development departments.'

Pharmaceutical science & technology today·2000
Same author

Measurement of excitation functions in the reactions 197Au(11C, xn)208-xAt using a radioactive 11C beam

Physical review letters·2000
Same author

Reply

The Journal of infectious diseases·2000
Same journal

Monitor: progress and profiles.

Pharmaceutical science & technology today·2001
Same journal

Recent technological advances in oral drug delivery - a review.

Pharmaceutical science & technology today·2001
Same journal

The formulation of biopharmaceutical products.

Pharmaceutical science & technology today·2001
Same journal

Live bacterial vectors for intranasal delivery of protective antigens.

Pharmaceutical science & technology today·2001
Same journal

Computer-integrated drug design provides new leads for thromboembolic disorders.

Pharmaceutical science & technology today·2001
Same journal

The Clinical Trials Directive - a new regulatory regime for Europe?

Pharmaceutical science & technology today·2001
See all related articles

This study introduces PROFITS (PRoduct Formulation using InTelligent Software), a platform designed for sharing insights and challenges in product formulation. It facilitates collaboration among professionals in the field.

Area of Science:

  • Pharmaceutical Sciences
  • Chemical Engineering
  • Materials Science

Background:

  • Product formulation is a complex process involving the integration of various scientific disciplines.
  • Effective knowledge sharing is crucial for addressing challenges and advancing formulation technologies.
  • Existing platforms may not adequately cater to the specific needs of product formulation professionals.

Purpose of the Study:

  • To introduce and describe the PROFITS (PRoduct Formulation using InTelligent Software) system.
  • To highlight the importance of a dedicated platform for sharing ideas, experiences, and issues in product formulation.
  • To foster collaboration and accelerate innovation within the formulation science community.

Main Methods:

  • PROFITS is conceptualized as an intelligent software system.

Related Experiment Videos

  • The system is designed to facilitate the exchange of information among users.
  • Key features would likely include discussion forums, case study repositories, and expert Q&A sections.
  • Main Results:

    • The primary outcome is the establishment of a collaborative environment for formulation scientists.
    • PROFITS aims to streamline the dissemination of best practices and problem-solving strategies.
    • The software is intended to serve as a repository for valuable industry knowledge.

    Conclusions:

    • PROFITS offers a novel solution for enhancing communication and knowledge transfer in product formulation.
    • The platform has the potential to significantly impact the efficiency and success rate of product development.
    • Continued development and adoption of PROFITS can lead to substantial advancements in formulation science.